Get started
Author

Capucine Cahuzac

Hepatic failure in disorders of oxidative phosphorylation with neonatal onset
1991 · Valérie Cormier, Pierre Rustin, et al. · The Journal of Pediatrics · 59
LBA-5 ANCHOR CRC: a single-arm, phase 2 study of encorafenib, binimetinib plus cetuximab in previously untreated BRAF V600E-mutant metastatic colorectal cancer
2020 · A. Grothey, J. Tabernero, et al. · Annals of Oncology · 37
PDF
Avelumab as second-line or later treatment in patients with metastatic Merkel cell carcinoma: Analysis of real-world outcomes in France using the CARADERM database linked to the French national healthcare database
2024 · Laurent Mortier, Astrid Blom, et al. · European Journal of Cancer · 11
PDF
365P Interim analysis (IA) of the giredestrant (G) + samuraciclib (SAMURA) arm in MORPHEUS breast cancer (BC): A phase I/II study of G treatment (tx) combinations in patients (pts) with oestrogen receptor-positive (ER+), HER2-negative, locally advanced/metastatic BC (LA/mBC)
2024 · M. Oliveira, M. Gion Cortes, et al. · Annals of Oncology · 3
PDF
Avelumab as second-line or later (2L+) treatment in patients (pts) with metastatic Merkel cell carcinoma (mMCC): Analysis of real-world outcomes in France using the CARADERM registry and the French national healthcare database.
2023 · Astrid Blom Fily, Laurent Mortier, et al. · Journal of Clinical Oncology · 3
PDF
Pos1147 Efficacy of Cenerimod in Patients With High Ifn-1 Gene Expression Signature and High Anti-dsdna Antibody Levels: Post-hoc Analysis From a Phase 2 Study
2023 · A. Askanase, D. D'cruz, et al. · Annals of the Rheumatic Diseases · 2
PDF
RWD87 Retrospective Observational Study of Patients with Metastatic Merkel Cell Carcinoma (mMCC) Using the Caraderm Database Linked to the French National Health Data System (SNDS)
2023 · A. Blom, L. Mortier, et al. · Value in Health
PDF
Avélumab en traitement de 1re ligne des patients atteints d’un carcinome à cellules de Merkel métastatique : analyse des données en vie réelle en France à partir de bases de données de cancers rares et du Système National de Données de Santé (SNDS)
2023 · A. Blom, L. Mortier, et al. · Annales de Dermatologie et de Vénéréologie - FMC
1148P Avelumab as second-line or later (2L+) treatment (tx) in patients (pts) with metastatic Merkel cell carcinoma (mMCC): Real-world tx patterns in France
2023 · A. Blom Fily, L. Mortier, et al. · Annals of Oncology
PDF
Works count: 9
Citation count: 115
H-index: 3
I10-index: 3
Year
Topic
Type